• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MSB

MESOBLAST LIMITED - Announcements

0.66% ! $2.31
Market Cap $2.931B  !

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

Announcements



MSB FDA Grants Mesoblast Fast Track Designation For GVHDPRICE SENSITIVE07/03/17 download Created with Sketch. 92.34KB
MSB Mesoblast Provides Half Year Results And Corporate Update27/02/17 download Created with Sketch. 219.84KB
MSB Half Year Results Presentation27/02/17 download Created with Sketch. 2.68MB
MSB Half Year Report and Accounts (including Appendix 4D)PRICE SENSITIVE27/02/17 download Created with Sketch. 3.87MB
MSB Presentation On Mesoblast RA P2 9 Month Trial Results16/02/17 download Created with Sketch. 2.5MB
MSB Positive Nine Month RA Results For Mesoblast Cell TherapyPRICE SENSITIVE16/02/17 download Created with Sketch. 161.63KB
MSB Published Results Show MSB Cells Effective In RA ModelPRICE SENSITIVE13/02/17 download Created with Sketch. 115.34KB
MSB Release of shares from voluntary escrow10/02/17 download Created with Sketch. 83.69KB
MSB Appendix 4C - quarterlyPRICE SENSITIVE31/01/17 download Created with Sketch. 60.43KB
MSB Mesoblast Director Recognized For Cardiovascular LeadershipPRICE SENSITIVE31/01/17 download Created with Sketch. 91.54KB
MSB MSB Presentation To Annual J.P.Morgan Healthcare Conference13/01/17 download Created with Sketch. 3.7MB
MSB Presentation at JP Morgan Healthcare Conference11/01/17 download Created with Sketch. 285.21KB
MSB MSB Receives A$29.6Million, Appendix 3B Share Issue09/01/17 download Created with Sketch. 237.85KB
MSB Mesoblast And Mallinckrodt Enter Into AgreementPRICE SENSITIVE23/12/16 download Created with Sketch. 95.59KB
MSB New US Accelerated Approval Pathway For Cell Therapies09/12/16 download Created with Sketch. 91.21KB
MSB S&P DJ Indices Announces December Quarterly Rebalance09/12/16 download Created with Sketch. 111.26KB
MSB MD Anderson and NIH Fund Trial Using Mesoblast TechnologiesPRICE SENSITIVE06/12/16 download Created with Sketch. 94.77KB
MSB Results of Meeting22/11/16 download Created with Sketch. 198.05KB
MSB CEO Presentation to 2016 Annual General Meeting22/11/16 download Created with Sketch. 932.09KB
MSB Chairman's Address to Shareholders22/11/16 download Created with Sketch. 267.86KB
MSB Mesoblast Provides Corporate Update and Q1 Financial ResultsPRICE SENSITIVE15/11/16 download Created with Sketch. 204.69KB
MSB First Quarter Results Presentation15/11/16 download Created with Sketch. 552.26KB
MSB First Quarter Results On Form 6KPRICE SENSITIVE15/11/16 download Created with Sketch. 2.03MB
MSB Successful Interim Futility Analysis In P3 Trial for GVHDPRICE SENSITIVE14/11/16 download Created with Sketch. 104.7KB
MSB Appendix 4C - quarterly-MSB.AX PRICE SENSITIVE31/10/16 download Created with Sketch. 57.51KB
MSB Annual Report to shareholders-MSB.AX 21/10/16 download Created with Sketch. 5.98MB
MSB Notice of Annual General Meeting/Proxy Form-MSB.AX 21/10/16 download Created with Sketch. 289.87KB
MSB Appendix 4G And Corporate Governance Statement-MSB.AX 21/10/16 download Created with Sketch. 170.94KB
MSB Mesoblast Receives Frost & Sullivan 2016 Cell Therapy Award-MSB.AX 18/10/16 download Created with Sketch. 105.77KB
MSB MSB Japan Strategy Highlighted At Business Council Meeting-MSB.AX PRICE SENSITIVE12/10/16 download Created with Sketch. 90.23KB
MSB Mesoblast Phase 2 Diabetic Kidney Disease Results Published-MSB.AX PRICE SENSITIVE06/10/16 download Created with Sketch. 116.34KB
MSB Mesoblast Appoints Bill Burns As Vice Chairman-MSB.AX 01/09/16 download Created with Sketch. 86.13KB
MSB Annual Financial Results Presentation-MSB.AX 28/08/16 download Created with Sketch. 659.55KB
MSB Preliminary Final Report (Including Appendix 4E)-MSB.AX PRICE SENSITIVE28/08/16 download Created with Sketch. 5.63MB
MSB Mesoblast Reports on Annual and Fourth Quarter Results-MSB.AX PRICE SENSITIVE28/08/16 download Created with Sketch. 210.61KB
MSB Mesoblast Reports on Annual and Fourth Quarter Results-MSB.AX PRICE SENSITIVE25/08/16 download Created with Sketch. 210.61KB
MSB Annual Financial Results Presentation-MSB.AX 25/08/16 download Created with Sketch. 659.55KB
MSB Preliminary Final Report (Including Appendix 4E)-MSB.AX PRICE SENSITIVE25/08/16 download Created with Sketch. 5.63MB
MSB Appendix 3B-MSB.AX 19/08/16 download Created with Sketch. 179.37KB
MSB MSB Strengthens US Patent Portfolio For Rheumatic Diseases-MSB.AX PRICE SENSITIVE17/08/16 download Created with Sketch. 128.67KB
MSB Mesoblast P2 Results Show Dose-Related Improvements In RA-MSB.AX PRICE SENSITIVE09/08/16 download Created with Sketch. 138.83KB
MSB Presentation On Mesoblast RA P2 Trial Results-MSB.AX 09/08/16 download Created with Sketch. 1.88MB
MSB MSB Back Pain Results Presented, Receive Best Science Award-MSB.AX PRICE SENSITIVE01/08/16 download Created with Sketch. 132.68KB
MSB Appendix 4C - quarterly-MSB.AX PRICE SENSITIVE29/07/16 download Created with Sketch. 167.43KB
MSB Update on Heart Failure Trial and Funding of Operations-MSB.AX PRICE SENSITIVE01/07/16 download Created with Sketch. 116.68KB
MSB Reinstatement to Official Quotation-MSB.AX PRICE SENSITIVE14/06/16 download Created with Sketch. 249.23KB
MSB Update on Global Heart Failure Program-MSB.AX PRICE SENSITIVE14/06/16 download Created with Sketch. 120.11KB
MSB Extension of Voluntary Suspension-MSB.AX 10/06/16 download Created with Sketch. 61.12KB
MSB Suspension from Official Quotation-MSB.AX PRICE SENSITIVE03/06/16 download Created with Sketch. 322.37KB
MSB Trading Halt-MSB.AX PRICE SENSITIVE01/06/16 download Created with Sketch. 323.92KB
MSB Mesoblast Receives $6.2m From Aus Govt For R&D-MSB.AX PRICE SENSITIVE20/05/16 download Created with Sketch. 64.7KB
MSB Ceasing to be a substantial holder-JP Morgan-MSB.AX 13/05/16 download Created with Sketch. 1.38MB
MSB Ceasing to be a substantial holder-MSB.AX 12/05/16 download Created with Sketch. 443.23KB
MSB Change in substantial holding-MSB.AX 12/05/16 download Created with Sketch. 552.8KB
MSB Mesoblast Provides Q3 Financial Results and Corporate Update-MSB.AX PRICE SENSITIVE10/05/16 download Created with Sketch. 311.13KB
MSB Third Quarter Results Presentation-MSB.AX 10/05/16 download Created with Sketch. 3.61MB
MSB Third Quarter Financial Results On Form 6-K-MSB.AX PRICE SENSITIVE10/05/16 download Created with Sketch. 1.84MB
MSB Change in substantial holding-J.P.Morgan-MSB.AX 09/05/16 download Created with Sketch. 2.83MB
MSB Change in substantial holding-MSB.AX 09/05/16 download Created with Sketch. 3.76MB
MSB Appendix 4C - quarterly-MSB.AX PRICE SENSITIVE28/04/16 download Created with Sketch. 166.98KB
MSB Appendix 3B and Prospectus for Issue of Employee Options-MSB.AX 28/04/16 download Created with Sketch. 565.82KB
MSB Release of Shares from Voluntary Escrow-MSB.AX 19/04/16 download Created with Sketch. 83.87KB
MSB Mesoblast Cells Show Disease Modifying Effects on Knee OAPRICE SENSITIVE01/04/16 download Created with Sketch. 159.69KB
MSB Key US Patent Granted For Treatment Of Rheumatoid ArthritisPRICE SENSITIVE24/03/16 download Created with Sketch. 132.13KB
MSB Mesoblast Technology Shows Potential In Type 1 Diabetes17/03/16 download Created with Sketch. 120.89KB
MSB Appendix 3B26/02/16 download Created with Sketch. 275.04KB
MSB GVHD Product Launched In JapanPRICE SENSITIVE24/02/16 download Created with Sketch. 86.57KB
MSB Increased Survival Using MSB Cells In Children With aGVHDPRICE SENSITIVE22/02/16 download Created with Sketch. 128.87KB
MSB Mesoblast Reports on First Half and Second Quarter Results17/02/16 download Created with Sketch. 986.9KB
MSB Half Year Results Presentation17/02/16 download Created with Sketch. 600.51KB
MSB Half Yearly Report and Accounts (including Appendix 4D)PRICE SENSITIVE17/02/16 download Created with Sketch. 3.82MB
MSB MSB Therapy Shows Benefit In First Cohort Of RA PatientsPRICE SENSITIVE16/02/16 download Created with Sketch. 126.5KB
MSB Appendix 4C - quarterlyPRICE SENSITIVE28/01/16 download Created with Sketch. 946.58KB
MSB Change in substantial holding19/01/16 download Created with Sketch. 4.84MB
MSB CEO Presentation at JP Morgan Healthcare Conference14/01/16 download Created with Sketch. 6.46MB
MSB Phase 3 Heart Failure Trial Size Substantially ReducedPRICE SENSITIVE11/01/16 download Created with Sketch. 105.87KB
MSB Mesoblast to Present at J.P. Morgan Healthcare Conference08/01/16 download Created with Sketch. 63.63KB
MSB Mesoblast Provides Strategic Update and Q1 Financial ResultsPRICE SENSITIVE17/12/15 download Created with Sketch. 197.87KB
MSB Strategic Update and Q1 Financial Results PresentationPRICE SENSITIVE17/12/15 download Created with Sketch. 382.06KB
MSB Quarterly Results Filed on Form 6-K with SECPRICE SENSITIVE17/12/15 download Created with Sketch. 2.09MB
MSB Change of Director's Interest Notice04/12/15 download Created with Sketch. 71.94KB
MSB Change in substantial holding - J.P. Morgan (Updated)03/12/15 download Created with Sketch. 1.98MB
MSB Change in substantial holding - J.P. Morgan02/12/15 download Created with Sketch. 1.75MB
MSB Change of Director's Interest Notice30/11/15 download Created with Sketch. 70.6KB
MSB Change of Director's Interest Notice27/11/15 download Created with Sketch. 185.21KB
MSB Change in substantial holding27/11/15 download Created with Sketch. 115.48KB
MSB MSB's Japan Licensee Receives Pricing For TEMCELLPRICE SENSITIVE26/11/15 download Created with Sketch. 90.46KB
MSB Investor Update23/11/15 download Created with Sketch. 219.6KB
MSB Change of Director's Interest Notice23/11/15 download Created with Sketch. 98.94KB
MSB Change in substantial holding19/11/15 download Created with Sketch. 963.22KB
MSB Closing Of Public Offering On Nasdaq19/11/15 download Created with Sketch. 178.89KB
MSB Change in substantial holding - J.P. Morgan18/11/15 download Created with Sketch. 2.83MB
MSB Change in substantial holding17/11/15 download Created with Sketch. 4.59MB
MSB Appendix 3B16/11/15 download Created with Sketch. 278.9KB
MSB Reinstatement to Official QuotationPRICE SENSITIVE16/11/15 download Created with Sketch. 218.43KB
MSB Mesoblast Lists On NasdaqPRICE SENSITIVE16/11/15 download Created with Sketch. 1.28MB
MSB Becoming a substantial holder - J.P. Morgan05/11/15 download Created with Sketch. 7.05MB
MSB Becoming a substantial holder04/11/15 download Created with Sketch. 5.37MB
MSB MSB Files US Registration Statement, Nasdaq Listing Planned03/11/15 download Created with Sketch. 1.45MB
MSB Plan To Conduct Registered IPO In United States30/10/15 download Created with Sketch. 62.85KB
MSB FDA Grants Mesoblast Fast Track Designation For GVHD
07/03/17PRICE SENSITIVE download Created with Sketch. 92.34KB
MSB Mesoblast Provides Half Year Results And Corporate Update
27/02/17 download Created with Sketch. 219.84KB
MSB Half Year Results Presentation
27/02/17 download Created with Sketch. 2.68MB
MSB Half Year Report and Accounts (including Appendix 4D)
27/02/17PRICE SENSITIVE download Created with Sketch. 3.87MB
MSB Presentation On Mesoblast RA P2 9 Month Trial Results
16/02/17 download Created with Sketch. 2.5MB
MSB Positive Nine Month RA Results For Mesoblast Cell Therapy
16/02/17PRICE SENSITIVE download Created with Sketch. 161.63KB
MSB Published Results Show MSB Cells Effective In RA Model
13/02/17PRICE SENSITIVE download Created with Sketch. 115.34KB
MSB Release of shares from voluntary escrow
10/02/17 download Created with Sketch. 83.69KB
MSB Appendix 4C - quarterly
31/01/17PRICE SENSITIVE download Created with Sketch. 60.43KB
MSB Mesoblast Director Recognized For Cardiovascular Leadership
31/01/17PRICE SENSITIVE download Created with Sketch. 91.54KB
MSB MSB Presentation To Annual J.P.Morgan Healthcare Conference
13/01/17 download Created with Sketch. 3.7MB
MSB Presentation at JP Morgan Healthcare Conference
11/01/17 download Created with Sketch. 285.21KB
MSB MSB Receives A$29.6Million, Appendix 3B Share Issue
09/01/17 download Created with Sketch. 237.85KB
MSB Mesoblast And Mallinckrodt Enter Into Agreement
23/12/16PRICE SENSITIVE download Created with Sketch. 95.59KB
MSB New US Accelerated Approval Pathway For Cell Therapies
09/12/16 download Created with Sketch. 91.21KB
MSB S&P DJ Indices Announces December Quarterly Rebalance
09/12/16 download Created with Sketch. 111.26KB
MSB MD Anderson and NIH Fund Trial Using Mesoblast Technologies
06/12/16PRICE SENSITIVE download Created with Sketch. 94.77KB
MSB Results of Meeting
22/11/16 download Created with Sketch. 198.05KB
MSB CEO Presentation to 2016 Annual General Meeting
22/11/16 download Created with Sketch. 932.09KB
MSB Chairman's Address to Shareholders
22/11/16 download Created with Sketch. 267.86KB
MSB Mesoblast Provides Corporate Update and Q1 Financial Results
15/11/16PRICE SENSITIVE download Created with Sketch. 204.69KB
MSB First Quarter Results Presentation
15/11/16 download Created with Sketch. 552.26KB
MSB First Quarter Results On Form 6K
15/11/16PRICE SENSITIVE download Created with Sketch. 2.03MB
MSB Successful Interim Futility Analysis In P3 Trial for GVHD
14/11/16PRICE SENSITIVE download Created with Sketch. 104.7KB
MSB Appendix 4C - quarterly-MSB.AX
31/10/16PRICE SENSITIVE download Created with Sketch. 57.51KB
MSB Annual Report to shareholders-MSB.AX
21/10/16 download Created with Sketch. 5.98MB
MSB Notice of Annual General Meeting/Proxy Form-MSB.AX
21/10/16 download Created with Sketch. 289.87KB
MSB Appendix 4G And Corporate Governance Statement-MSB.AX
21/10/16 download Created with Sketch. 170.94KB
MSB Mesoblast Receives Frost & Sullivan 2016 Cell Therapy Award-MSB.AX
18/10/16 download Created with Sketch. 105.77KB
MSB MSB Japan Strategy Highlighted At Business Council Meeting-MSB.AX
12/10/16PRICE SENSITIVE download Created with Sketch. 90.23KB
MSB Mesoblast Phase 2 Diabetic Kidney Disease Results Published-MSB.AX
06/10/16PRICE SENSITIVE download Created with Sketch. 116.34KB
MSB Mesoblast Appoints Bill Burns As Vice Chairman-MSB.AX
01/09/16 download Created with Sketch. 86.13KB
MSB Annual Financial Results Presentation-MSB.AX
28/08/16 download Created with Sketch. 659.55KB
MSB Preliminary Final Report (Including Appendix 4E)-MSB.AX
28/08/16PRICE SENSITIVE download Created with Sketch. 5.63MB
MSB Mesoblast Reports on Annual and Fourth Quarter Results-MSB.AX
28/08/16PRICE SENSITIVE download Created with Sketch. 210.61KB
MSB Mesoblast Reports on Annual and Fourth Quarter Results-MSB.AX
25/08/16PRICE SENSITIVE download Created with Sketch. 210.61KB
MSB Annual Financial Results Presentation-MSB.AX
25/08/16 download Created with Sketch. 659.55KB
MSB Preliminary Final Report (Including Appendix 4E)-MSB.AX
25/08/16PRICE SENSITIVE download Created with Sketch. 5.63MB
MSB Appendix 3B-MSB.AX
19/08/16 download Created with Sketch. 179.37KB
MSB MSB Strengthens US Patent Portfolio For Rheumatic Diseases-MSB.AX
17/08/16PRICE SENSITIVE download Created with Sketch. 128.67KB
MSB Mesoblast P2 Results Show Dose-Related Improvements In RA-MSB.AX
09/08/16PRICE SENSITIVE download Created with Sketch. 138.83KB
MSB Presentation On Mesoblast RA P2 Trial Results-MSB.AX
09/08/16 download Created with Sketch. 1.88MB
MSB MSB Back Pain Results Presented, Receive Best Science Award-MSB.AX
01/08/16PRICE SENSITIVE download Created with Sketch. 132.68KB
MSB Appendix 4C - quarterly-MSB.AX
29/07/16PRICE SENSITIVE download Created with Sketch. 167.43KB
MSB Update on Heart Failure Trial and Funding of Operations-MSB.AX
01/07/16PRICE SENSITIVE download Created with Sketch. 116.68KB
MSB Reinstatement to Official Quotation-MSB.AX
14/06/16PRICE SENSITIVE download Created with Sketch. 249.23KB
MSB Update on Global Heart Failure Program-MSB.AX
14/06/16PRICE SENSITIVE download Created with Sketch. 120.11KB
MSB Extension of Voluntary Suspension-MSB.AX
10/06/16 download Created with Sketch. 61.12KB
MSB Suspension from Official Quotation-MSB.AX
03/06/16PRICE SENSITIVE download Created with Sketch. 322.37KB
MSB Trading Halt-MSB.AX
01/06/16PRICE SENSITIVE download Created with Sketch. 323.92KB
MSB Mesoblast Receives $6.2m From Aus Govt For R&D-MSB.AX
20/05/16PRICE SENSITIVE download Created with Sketch. 64.7KB
MSB Ceasing to be a substantial holder-JP Morgan-MSB.AX
13/05/16 download Created with Sketch. 1.38MB
MSB Ceasing to be a substantial holder-MSB.AX
12/05/16 download Created with Sketch. 443.23KB
MSB Change in substantial holding-MSB.AX
12/05/16 download Created with Sketch. 552.8KB
MSB Mesoblast Provides Q3 Financial Results and Corporate Update-MSB.AX
10/05/16PRICE SENSITIVE download Created with Sketch. 311.13KB
MSB Third Quarter Results Presentation-MSB.AX
10/05/16 download Created with Sketch. 3.61MB
MSB Third Quarter Financial Results On Form 6-K-MSB.AX
10/05/16PRICE SENSITIVE download Created with Sketch. 1.84MB
MSB Change in substantial holding-J.P.Morgan-MSB.AX
09/05/16 download Created with Sketch. 2.83MB
MSB Change in substantial holding-MSB.AX
09/05/16 download Created with Sketch. 3.76MB
MSB Appendix 4C - quarterly-MSB.AX
28/04/16PRICE SENSITIVE download Created with Sketch. 166.98KB
MSB Appendix 3B and Prospectus for Issue of Employee Options-MSB.AX
28/04/16 download Created with Sketch. 565.82KB
MSB Release of Shares from Voluntary Escrow-MSB.AX
19/04/16 download Created with Sketch. 83.87KB
MSB Mesoblast Cells Show Disease Modifying Effects on Knee OA
01/04/16PRICE SENSITIVE download Created with Sketch. 159.69KB
MSB Key US Patent Granted For Treatment Of Rheumatoid Arthritis
24/03/16PRICE SENSITIVE download Created with Sketch. 132.13KB
MSB Mesoblast Technology Shows Potential In Type 1 Diabetes
17/03/16 download Created with Sketch. 120.89KB
MSB Appendix 3B
26/02/16 download Created with Sketch. 275.04KB
MSB GVHD Product Launched In Japan
24/02/16PRICE SENSITIVE download Created with Sketch. 86.57KB
MSB Increased Survival Using MSB Cells In Children With aGVHD
22/02/16PRICE SENSITIVE download Created with Sketch. 128.87KB
MSB Mesoblast Reports on First Half and Second Quarter Results
17/02/16 download Created with Sketch. 986.9KB
MSB Half Year Results Presentation
17/02/16 download Created with Sketch. 600.51KB
MSB Half Yearly Report and Accounts (including Appendix 4D)
17/02/16PRICE SENSITIVE download Created with Sketch. 3.82MB
MSB MSB Therapy Shows Benefit In First Cohort Of RA Patients
16/02/16PRICE SENSITIVE download Created with Sketch. 126.5KB
MSB Appendix 4C - quarterly
28/01/16PRICE SENSITIVE download Created with Sketch. 946.58KB
MSB Change in substantial holding
19/01/16 download Created with Sketch. 4.84MB
MSB CEO Presentation at JP Morgan Healthcare Conference
14/01/16 download Created with Sketch. 6.46MB
MSB Phase 3 Heart Failure Trial Size Substantially Reduced
11/01/16PRICE SENSITIVE download Created with Sketch. 105.87KB
MSB Mesoblast to Present at J.P. Morgan Healthcare Conference
08/01/16 download Created with Sketch. 63.63KB
MSB Mesoblast Provides Strategic Update and Q1 Financial Results
17/12/15PRICE SENSITIVE download Created with Sketch. 197.87KB
MSB Strategic Update and Q1 Financial Results Presentation
17/12/15PRICE SENSITIVE download Created with Sketch. 382.06KB
MSB Quarterly Results Filed on Form 6-K with SEC
17/12/15PRICE SENSITIVE download Created with Sketch. 2.09MB
MSB Change of Director's Interest Notice
04/12/15 download Created with Sketch. 71.94KB
MSB Change in substantial holding - J.P. Morgan (Updated)
03/12/15 download Created with Sketch. 1.98MB
MSB Change in substantial holding - J.P. Morgan
02/12/15 download Created with Sketch. 1.75MB
MSB Change of Director's Interest Notice
30/11/15 download Created with Sketch. 70.6KB
MSB Change of Director's Interest Notice
27/11/15 download Created with Sketch. 185.21KB
MSB Change in substantial holding
27/11/15 download Created with Sketch. 115.48KB
MSB MSB's Japan Licensee Receives Pricing For TEMCELL
26/11/15PRICE SENSITIVE download Created with Sketch. 90.46KB
MSB Investor Update
23/11/15 download Created with Sketch. 219.6KB
MSB Change of Director's Interest Notice
23/11/15 download Created with Sketch. 98.94KB
MSB Change in substantial holding
19/11/15 download Created with Sketch. 963.22KB
MSB Closing Of Public Offering On Nasdaq
19/11/15 download Created with Sketch. 178.89KB
MSB Change in substantial holding - J.P. Morgan
18/11/15 download Created with Sketch. 2.83MB
MSB Change in substantial holding
17/11/15 download Created with Sketch. 4.59MB
MSB Appendix 3B
16/11/15 download Created with Sketch. 278.9KB
MSB Reinstatement to Official Quotation
16/11/15PRICE SENSITIVE download Created with Sketch. 218.43KB
MSB Mesoblast Lists On Nasdaq
16/11/15PRICE SENSITIVE download Created with Sketch. 1.28MB
MSB Becoming a substantial holder - J.P. Morgan
05/11/15 download Created with Sketch. 7.05MB
MSB Becoming a substantial holder
04/11/15 download Created with Sketch. 5.37MB
MSB MSB Files US Registration Statement, Nasdaq Listing Planned
03/11/15 download Created with Sketch. 1.45MB
MSB Plan To Conduct Registered IPO In United States
30/10/15 download Created with Sketch. 62.85KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$2.31
Change
0.015(0.66%)
Mkt cap ! $2.931B
Open High Low Value Volume
$2.31 $2.32 $2.31 $314.0K 135.8K

Buyers (Bids)

No. Vol. Price($)
12 34136 $2.30
 

Sellers (Offers)

Price($) Vol. No.
$2.31 23205 2
View Market Depth
Last trade - 10.01am 13/08/2025 (20 minute delay) ?
Last
$2.32
  Change
0.015 ( 1.63 %)
Open High Low Volume
$2.32 $2.33 $2.31 49184
Last updated 10.22am 13/08/2025 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.